cancer biomarkers

Sixteen years ago, Dr. Michael Gnant was portrayed in CancerWorld as a surgical oncologist unafraid to push boundaries in breast cancer care. Today, his perspective reflects not retreat but evolution. The boundary-pusher remains, but his focus has widened. His work…

For decades, early cancer detection has predominantly relied on organ-specific screening programs—such as mammography, Pap test, or colonoscopy—to detect malignancies as early as possible. While these approaches have indisputably saved lives, they inherently capture only a limited range of cancers,…

The alpha-synuclein, a protein long associated with Parkinson’s disease may hold the key to melanoma proliferation. The study, published in Science Advances, on 9 April, suggests that while excess alpha-synuclein results in cell death in neurons, conversely, it enables uncontrolled…